Emergent BioSolutions Inc. · BX:ER4

Emergent BioSolutions Inc. financial statements

Emergent BioSolutions Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue742.9M1.04B1.05B1.12B1.77B1.58B1.11B782.4M560.9M488.8M
Cost of revenue326.2M681.3M705.4M693.1M748.1M537.0M433.5M322.3M187.7M126.3M
Gross profit416.7M362.3M317.6M383.0M891.3M925.2M672.5M460.1M373.2M362.5M
Research and development53.2M70.7M111.4M188.3M235.2M237.9M226.2M142.8M97.4M106.9M
Selling, general and administrative186.1M308.0M368.4M339.5M348.7M304.1M273.5M202.5M142.9M143.1M
Operating income100.1M-108.7M-726.4M-170.0M341.4M438.5M114.1M89.8M124.3M105.5M
Depreciation and amortization95.8M108.8M125.1M143.3M123.8M50.1M49.5M36.3M32.2M28.0M
EBITDA195.9M100.0K-601.3M-26.7M465.2M488.6M163.6M126.1M156.5M133.5M
Interest expense59.3M71.0M87.9M37.3M34.5M31.3M38.4M9.90M6.60M7.60M
Income before tax82.8M-142.9M-731.2M-219.0M303.2M411.9M77.4M81.5M118.6M99.2M
Income tax30.2M47.7M29.3M-7.40M83.7M106.1M22.9M18.8M36.0M36.7M
Net income52.6M-190.6M-760.5M-211.6M219.5M305.8M54.5M62.7M82.6M51.8M
Earnings per share, basic0.98-3.60-14.85-4.224.105.801.061.251.981.29
Earnings per share, diluted0.93-3.60-14.85-4.224.065.681.041.221.711.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents205.4M99.5M111.7M642.6M576.1M621.3M167.8M112.2M178.3M271.5M
Receivables84.2M154.5M191.0M159.2M278.9M230.9M270.7M262.5M143.7M138.5M
Inventory343.4M311.7M328.9M350.7M344.5M307.0M222.5M205.8M142.8M74.0M
Current assets662.5M598.7M679.5M1.21B1.27B1.20B686.2M620.8M485.4M510.2M
Property, plant and equipment205.4M270.6M382.8M817.6M800.1M644.1M542.3M510.2M407.2M376.4M
Goodwill000218.2M224.9M266.7M266.6M259.7M49.1M41.0M
Total assets1.32B1.39B1.82B3.17B2.96B2.88B2.33B2.23B1.07B970.1M
Accounts payable55.6M60.9M112.2M103.5M128.9M136.1M94.8M80.7M41.8M34.6M
Current liabilities132.2M162.4M651.3M1.23B374.0M384.5M216.3M200.4M100.1M105.9M
Long-term debt572.1M663.7M446.5M448.5M809.4M841.0M798.4M784.5M13.5M248.1M
Total debt589.7M700.0M868.4M1.41B849.6M885.5M822.5M808.8M13.6M248.1M
Total liabilities796.0M906.9M1.17B1.78B1.35B1.44B1.24B1.22B157.9M373.9M
Shareholders' equity522.6M482.8M649.3M1.39B1.61B1.45B1.09B1.01B912.3M596.2M
Shares outstanding52.1M54.3M52.2M50.1M51.3M53.1M51.7M51.2M49.4M40.6M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations170.6M58.7M-206.3M-34.1M320.2M536.9M188.0M41.8M208.1M54.6M
Capital spending-13.8M-22.9M-51.6M-115.8M-224.1M-141.9M-86.9M-72.1M-54.8M-76.2M
Free cash flow156.8M35.8M-257.9M-149.9M96.1M395.0M101.1M-30.3M153.3M-21.6M
Cash from investing69.4M125.2M212.3M-381.3M-224.1M-151.9M-96.9M-897.2M-249.9M-76.2M
Cash from financing-136.6M-190.0M-535.7M481.2M-141.0M69.5M-35.9M788.7M-51.4M-19.8M
Share buybacks-24.9M00-82.1M-106.0M00-100.0K-33.1M0
Change in cash103.5M-6.10M-530.9M66.3M-45.2M453.5M55.6M-66.9M-93.2M-41.3M